{
  "ticker": "IMU",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971993",
  "id": "02971993",
  "pages": 5,
  "price_sensitive": false,
  "date": "20250723",
  "time": "1743",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m2by7pmwyy3j.pdf",
  "summary": "### Summary of Director's Interest Notices:  \n\n#### **Leslie Chong (IMUGENE LIMITED)**  \n Travel Di- sures:  \n- **Direct shares increased**: +170,405 (now 2,618,782) via **exercise of Performance Rights** (nil consideration).  \n- **Performance Rights reduced**: -170,405 (now 51,877,139).  \n- No trading during closed period.  \n\n#### **Paul Hopper (IMUGENE LIMITED)**  \n- **Indirect shares increased**: +28,688 (now 11,960,754) via **exercise of Performance Rights** (nil consideration).  \n- **Performance Rights reduced**: -28,688 (now 136,266).  \n- No trading during closed period.  \n\n**Material Takeaway**:  \n- No capital impact (nil consideration shares issued). Minimal liquidity effect due to small volume relative to total holdings. Performance Rights remain substantial. Exercise likely precludes near-term selling pressure (locked-up shares).  \n\n*Omitted: Non-material holdings (options, legal boilerplate).*",
  "usage": {
    "prompt_tokens": 2171,
    "completion_tokens": 221,
    "total_tokens": 2392,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-23T09:16:07.075758"
}